Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. uri icon

Overview

publication date

  • December 15, 2023

Identity

PubMed Central ID

  • PMC10724149

Digital Object Identifier (DOI)

  • 10.1038/s41419-023-06339-1

PubMed ID

  • 38102106

Additional Document Info

volume

  • 14

issue

  • 12